CoChat
Sign Up
Cited by 684RNA and protein synthesis mechanismsRNA modifications and cancerRNA regulation and disease

The DOI matches its Crossref record; 58 of the 60 references it cites were found in a registry or an index.

Incorporation of pseudouridine into mRNA enhances translation by diminishing PKR activation

Open access
Anderson, Bart R., Muramatsu, Hiromi, Nallagatla, Subba R., Bevilacqua, Philip C., Sansing, Lauren H., Weissman, Drew, Karikó, Katalin·2010·Nucleic Acids Research
DOI 10.1093/nar/gkq347PMC PMC2943593
Open this paper in CoChat — free accountOpen PDF

Abstract

Previous studies have shown that the translation level of in vitro transcribed messenger RNA (mRNA) is enhanced when its uridines are replaced with pseudouridines; however, the reason for this enhancement has not been identified. Here, we demonstrate that in vitro transcripts containing uridine activate RNA-dependent protein kinase (PKR), which then phosphorylates translation initiation factor 2-alpha (eIF-2α), and inhibits translation. In contrast, in vitro transcribed mRNAs containing pseudouridine activate PKR to a lesser degree, and translation of pseudouridine-containing mRNAs is not repressed. RNA pull-down assays demonstrate that mRNA containing uridine is bound by PKR more efficiently than mRNA with pseudouridine. Finally, the role of PKR is validated by showing that pseudouridine- and uridine-containing RNAs were translated equally in PKR knockout cells. These results indicate that the enhanced translation of mRNAs containing pseudouridine, compared to those containing uridine, is mediated by decreased activation of PKR.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/nar/gkq347

Cites

58 of 58 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1. Translational inhibition by unmodified in vitro transcribed mRNA. (A) In vitro transcribed mRNAs encoding Renilla luciferase (Ren) and firefly luciferase (Luc) were synthesized with and without Ψ modifications then mixed (1 : 1 mass ratio) as indicated. The mixed mRNA was complexed with lipofectin and added to HEK293T cells seeded in 96-well plates (0.25 µg RNA/well). Cells were lysed 4 h after transfection and dual luciferase measurements were performed in aliquots (1/20th) of the lysates. Values presented are normalized to cells transfected with Ren and Luc mRNAs when both contained Ψ modifications. Error bars indicate the standard error of n = 3 samples. (B) Unmodified or pseudouridine-containing RNA was delivered to HEK293T cells by lipofection. Cells were subsequently incubated with 35S-methionine/cysteine supplemented medium, lysed, and proteins were TCA precipitated. Data are presented as percentage of counts obtained from mock transfected cells. Data shown are mean values from three independent experiments ± SEM.
Figure 1. Translational inhibition by unmodified in vitro transcribed mRNA. (A) In vitro transcribed mRNAs encoding Renilla luciferase (Ren) and firefly luciferase (Luc) were synthesized with and without Ψ modifications then mixed (1 : 1 mass ratio) as indicated. The mixed mRNA was complexed with lipofectin and added to HEK293T cells seeded in 96-well plates (0.25 µg RNA/well). Cells were lysed 4 h after transfection and dual luciferase measurements were performed in aliquots (1/20th) of the lysates. Values presented are normalized to cells transfected with Ren and Luc mRNAs when both contained Ψ modifications. Error bars indicate the standard error of n = 3 samples. (B) Unmodified or pseudouridine-containing RNA was delivered to HEK293T cells by lipofection. Cells were subsequently incubated with 35S-methionine/cysteine supplemented medium, lysed, and proteins were TCA precipitated. Data are presented as percentage of counts obtained from mock transfected cells. Data shown are mean values from three independent experiments ± SEM.CC BY-NC · PubMed Central
Figure 2. Activation of purified PKR by in vitro transcribed RNA. Purified PKR was incubated with γ-32P-ATP and in vitro transcribed mRNA for 10 min. Reaction products were separated by SDS–PAGE and imaged using phosphor storage radiography. Unmodified or Ψ-containing mRNAs encoding firefly luciferase contained triphosphates (ppp) or cap at their 5′-ends. Complete capping of RNA was achieved post-transcriptionally using vaccinia capping enzyme. Concentration of mRNA in reactions was 3.1, 6.2, 12.5 and 25 µg/ml. Quantified phosphorylation is presented as a bar graph below each band. Values were normalized to those obtained with 25 µg/ml uncapped, unmodified RNA. No RNA (−) and 79 bp dsRNA were used as negative and positive controls.
Figure 2. Activation of purified PKR by in vitro transcribed RNA. Purified PKR was incubated with γ-32P-ATP and in vitro transcribed mRNA for 10 min. Reaction products were separated by SDS–PAGE and imaged using phosphor storage radiography. Unmodified or Ψ-containing mRNAs encoding firefly luciferase contained triphosphates (ppp) or cap at their 5′-ends. Complete capping of RNA was achieved post-transcriptionally using vaccinia capping enzyme. Concentration of mRNA in reactions was 3.1, 6.2, 12.5 and 25 µg/ml. Quantified phosphorylation is presented as a bar graph below each band. Values were normalized to those obtained with 25 µg/ml uncapped, unmodified RNA. No RNA (−) and 79 bp dsRNA were used as negative and positive controls.CC BY-NC · PubMed Central
Figure 3. PKR activation by in vitro transcribed mRNA in cells. Unmodified or Ψ-containing in vitro transcribed firefly luciferase mRNA was delivered to cells by lipofection. Following RNA transfection, cells were lysed at 4 h (A) or at the indicated time (B), proteins were separated by SDS–PAGE, and assayed for phosphorylation of PKR (A) or eIF-2α (B) by western blotting. No RNA (−), poly(dC) and poly(I:C) were used as controls. Relative phosphorylation is indicated below each gel lane, calculated as phosphorylated band density divided by total band density and then normalized to the phosphorylation induced by unmodified RNA.
Figure 3. PKR activation by in vitro transcribed mRNA in cells. Unmodified or Ψ-containing in vitro transcribed firefly luciferase mRNA was delivered to cells by lipofection. Following RNA transfection, cells were lysed at 4 h (A) or at the indicated time (B), proteins were separated by SDS–PAGE, and assayed for phosphorylation of PKR (A) or eIF-2α (B) by western blotting. No RNA (−), poly(dC) and poly(I:C) were used as controls. Relative phosphorylation is indicated below each gel lane, calculated as phosphorylated band density divided by total band density and then normalized to the phosphorylation induced by unmodified RNA.CC BY-NC · PubMed Central
Figure 4. Translation of in vitro transcribed mRNA in the absence of PKR activity. (A) HEK293T cells were transfected with plasmids encoding protein inhibitors of PKR: swinepox C8L protein, wt vaccinia K3L, hyperactive K3L-H47R, inactive K3L-Y76A, or pG5 empty vector. Twenty-four hours later, unmodified or Ψ-modified in vitro transcribed mRNAs encoding firefly luciferase were delivered by lipofection, and luciferase activity was measured 4 h later. Data were normalized to values obtained when cells were first transfected with empty vector then with unmodified RNA. Presented data are mean values from three replicates ± SEM. (B) MEF cell lines derived from wild-type (WT) or transgenic mice that do not express functional PKR (PKR−/−) were transfected with unmodified or Ψ-containing in vitro transcribed mRNAs encoding firefly luciferase. Data were normalized to values obtained when cells were transfected with unmodified RNA and expressed as fold increase in translation of Ψ-containing mRNA over unmodified RNA. Values are from three replicate wells ± SEM, and are representative of at least three independently performed experiments. (C) WT and PKR−/– MEF cells were transfected with unmodified or Ψ-containing in vitro transcribed mRNAs encoding firefly luciferase, or mock transfected with no RNA (–). Cells were lysed 2 h following RNA transfection; proteins were then separated by SDS–PAGE and assayed for eIF-2α phosphorylation by western blotting. Relative phosphorylation is indicated above each gel lane, calculated as phosphorylated band density divided by total band density and then normalized to the phosphorylation induced by unmodified RNA in wild-type cells. Absence of PKR was also confirmed by western blotting.
Figure 4. Translation of in vitro transcribed mRNA in the absence of PKR activity. (A) HEK293T cells were transfected with plasmids encoding protein inhibitors of PKR: swinepox C8L protein, wt vaccinia K3L, hyperactive K3L-H47R, inactive K3L-Y76A, or pG5 empty vector. Twenty-four hours later, unmodified or Ψ-modified in vitro transcribed mRNAs encoding firefly luciferase were delivered by lipofection, and luciferase activity was measured 4 h later. Data were normalized to values obtained when cells were first transfected with empty vector then with unmodified RNA. Presented data are mean values from three replicates ± SEM. (B) MEF cell lines derived from wild-type (WT) or transgenic mice that do not express functional PKR (PKR−/−) were transfected with unmodified or Ψ-containing in vitro transcribed mRNAs encoding firefly luciferase. Data were normalized to values obtained when cells were transfected with unmodified RNA and expressed as fold increase in translation of Ψ-containing mRNA over unmodified RNA. Values are from three replicate wells ± SEM, and are representative of at least three independently performed experiments. (C) WT and PKR−/– MEF cells were transfected with unmodified or Ψ-containing in vitro transcribed mRNAs encoding firefly luciferase, or mock transfected with no RNA (–). Cells were lysed 2 h following RNA transfection; proteins were then separated by SDS–PAGE and assayed for eIF-2α phosphorylation by western blotting. Relative phosphorylation is indicated above each gel lane, calculated as phosphorylated band density divided by total band density and then normalized to the phosphorylation induced by unmodified RNA in wild-type cells. Absence of PKR was also confirmed by western blotting.CC BY-NC · PubMed Central
Figure 5. Ψ-containing mRNA does not inhibit PKR activation. An activating 200 bp dsRNA was mixed with a 5–125-fold mass excess of Ψ-containing in vitro transcribed firefly luciferase mRNA prior to incubation with purified PKR. Reaction products were separated by SDS–PAGE. Relative band densities are presented below each gel lane and normalized to dsRNA only. Data shown are representative of three independent experiments.
Figure 5. Ψ-containing mRNA does not inhibit PKR activation. An activating 200 bp dsRNA was mixed with a 5–125-fold mass excess of Ψ-containing in vitro transcribed firefly luciferase mRNA prior to incubation with purified PKR. Reaction products were separated by SDS–PAGE. Relative band densities are presented below each gel lane and normalized to dsRNA only. Data shown are representative of three independent experiments.CC BY-NC · PubMed Central
Figure 6. Ψ-containing mRNA does not pull-down PKR. Biotinylated in vitro transcribed unmodified or Ψ-containing RNAs were incubated with HEK293T cell lysates for 2 h. The RNA and bound proteins were pulled down using streptavidin-agarose beads. An aliquot of lysate that was incubated only with beads but without RNA (−) was also processed. Aliquots of pull-down proteins as well as the supernatants were separated by SDS–PAGE. PKR and PABP were detected by western blotting. Relative band densities of PKR divided by PABP compared to unmodified RNA are presented below each gel lane.
Figure 6. Ψ-containing mRNA does not pull-down PKR. Biotinylated in vitro transcribed unmodified or Ψ-containing RNAs were incubated with HEK293T cell lysates for 2 h. The RNA and bound proteins were pulled down using streptavidin-agarose beads. An aliquot of lysate that was incubated only with beads but without RNA (−) was also processed. Aliquots of pull-down proteins as well as the supernatants were separated by SDS–PAGE. PKR and PABP were detected by western blotting. Relative band densities of PKR divided by PABP compared to unmodified RNA are presented below each gel lane.CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 60 references

Cited by

Sorted by citations

See all 684

Related

Metadata

Authors
Anderson, B. R., Muramatsu, H., Nallagatla, S. R., Bevilacqua, P. C., Sansing, L. H., Weissman, D., & Karikó, K.
Affiliations
Pennsylvania State University (US)
Corresponding author
Karikó, Katalin
ORCID
Venue
Nucleic Acids Research
Publisher
Oxford University Press (OUP)
Published
2010-05-10
Volume
38
Issue
17
Pages
5884-5892
ISSN
  • 0305-1048 (ISSN-L)
  • 1362-4962
DOI
10.1093/nar/gkq347
PMC
PMC2943593
OpenAlex
W2156788486
Cited by
682
References
60
Citations by year
2026: 67 · 2025: 99 · 2024: 143 · 2023: 90 · 2022: 77 · 2021: 52 · 2020: 22 · 2019: 22 · 2018: 26 · 2017: 17 · 2016: 21 · 2015: 13 · 2014: 6 · 2013: 12 · 2012: 8
FWCI
3.49
Type
journal article
Language
en
Open access
Licence
Locations
  • Nucleic Acids Research (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • HighWire Press Open Archive (submittedVersion)
Funders
  • Cleveland Clinic
  • Cleveland Clinic Foundation
  • National Institutes of Health
  • National Heart, Lung, and Blood Institute (R42HL087688)
  • National Institute of General Medical Sciences (T32GM007229, R01GM058709)
  • National Institute of Allergy and Infectious Diseases (R01AI050484)
  • National Institute of Diabetes and Digestive and Kidney Diseases (T32DK007748)
  • National Institute of Dental and Craniofacial Research (R21DE019059)
  • National Center for Research Resources (T32RR007063)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA and protein synthesis mechanisms
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA modifications and cancer
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
Keywords
pseudouridine, mRNA translation, PKR, RNA-dependent protein kinase, eIF2α phosphorylation, translation initiation, uridine, in vitro transcribed mRNA, RNA-protein interactions
MeSH terms
Animals, Cell Line, Cells, Cultured, Humans, Pseudouridine, RNA, Messenger, Protein Biosynthesis, eIF-2 Kinase, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review